Medpace Holdings Operating Expenses 2014-2024 | MEDP

Medpace Holdings annual/quarterly operating expenses history and growth rate from 2014 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
  • Medpace Holdings operating expenses for the quarter ending September 30, 2024 were $0.421B, a 3.3% increase year-over-year.
  • Medpace Holdings operating expenses for the twelve months ending September 30, 2024 were $1.662B, a 14.18% increase year-over-year.
  • Medpace Holdings annual operating expenses for 2023 were $1.549B, a 31.13% increase from 2022.
  • Medpace Holdings annual operating expenses for 2022 were $1.181B, a 25.17% increase from 2021.
  • Medpace Holdings annual operating expenses for 2021 were $0.944B, a 24.36% increase from 2020.
Medpace Holdings Annual Operating Expenses
(Millions of US $)
2023 $1,549
2022 $1,181
2021 $944
2020 $759
2019 $734
2018 $604
2017 $371
2016 $369
2015 $338
2014 $322
2013 $214
Medpace Holdings Quarterly Operating Expenses
(Millions of US $)
2024-09-30 $421
2024-06-30 $423
2024-03-31 $407
2023-12-31 $411
2023-09-30 $408
2023-06-30 $382
2023-03-31 $348
2022-12-31 $318
2022-09-30 $306
2022-06-30 $291
2022-03-31 $267
2021-12-31 $254
2021-09-30 $242
2021-06-30 $236
2021-03-31 $212
2020-12-31 $205
2020-09-30 $184
2020-06-30 $175
2020-03-31 $195
2019-12-31 $194
2019-09-30 $186
2019-06-30 $179
2019-03-31 $175
2018-12-31 $161
2018-09-30 $152
2018-06-30 $147
2018-03-31 $143
2017-12-31 $97
2017-09-30 $93
2017-06-30 $90
2017-03-31 $91
2016-12-31 $95
2016-09-30 $95
2016-06-30 $92
2016-03-31 $87
2015-12-31
2015-09-30 $85
2014-12-31
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $11.301B $1.886B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $98.658B 12.24
Cencora (COR) United States $49.082B 18.10
DiDi Global (DIDIY) China $23.427B 0.00
ICON (ICLR) Ireland $17.504B 15.59
Natera (NTRA) United States $16.570B 0.00
Viatris (VTRS) United States $15.624B 4.81
Avantor (AVTR) United States $15.178B 22.75
Revvity (RVTY) United States $14.682B 25.50
BioMerieux (BMXMF) France $13.087B 0.00
CochLear (CHEOY) Australia $12.998B 0.00
Solventum (SOLV) United States $12.357B 0.00
Doximity (DOCS) United States $11.372B 67.31
Charles River Laboratories (CRL) United States $11.285B 21.81
HealthEquity (HQY) United States $8.756B 47.52
Sonic Healthcare (SKHHY) Australia $8.590B 0.00
Bausch + Lomb (BLCO) Canada $7.202B 33.53
Life Times (LTH) United States $5.139B 34.01
Sotera Health (SHC) United States $4.509B 24.12
Organon (OGN) United States $4.144B 4.18
Surgery Partners (SGRY) United States $3.996B 44.27
BrightSpring Health Services (BTSG) United States $3.489B 74.22
PACS (PACS) United States $3.347B 0.00
Alignment Healthcare (ALHC) United States $2.580B 0.00
Concentras Parent (CON) United States $2.505B 0.00
Ardent Health Partners (ARDT) United States $2.471B 0.00
Premier (PINC) United States $2.314B 11.55
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $2.016B 0.00
GoodRx Holdings (GDRX) United States $1.856B 48.90
Teladoc Health (TDOC) United States $1.689B 0.00
Progyny (PGNY) United States $1.540B 27.08
Pediatrix Medical (MD) United States $1.371B 13.41
Establishment Labs Holdings (ESTA) $1.266B 0.00
CareDx (CDNA) United States $1.252B 0.00
AMN Healthcare Services Inc (AMN) United States $1.058B 7.16
Embecta (EMBC) United States $0.910B 6.07
Agilon Health (AGL) United States $0.890B 0.00
InnovAge Holding (INNV) United States $0.809B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.723B 0.00
Auna S.A (AUNA) Luxembourg $0.516B 0.00
Sonida Senior Living (SNDA) United States $0.459B 0.00
DocGo (DCGO) United States $0.411B 15.46
Enhabit (EHAB) United States $0.403B 34.83
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
LifeMD (LFMD) United States $0.308B 0.00
Sera Prognostics (SERA) United States $0.248B 0.00
ModivCare (MODV) United States $0.231B 12.54
Beauty Health (SKIN) United States $0.218B 0.00
Biodesix (BDSX) United States $0.205B 0.00
Nutex Health (NUTX) United States $0.152B 0.00
MultiPlan (MPLN) United States $0.137B 0.00
Ascend Wellness Holdings (AAWH) United States $0.107B 0.00
So-Young (SY) China $0.088B 21.28
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.054B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.042B 1.10
Co-Diagnostics (CODX) United States $0.038B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00